Cellares stated that this represents the first time a Treg therapy will be manufactured on the Cell Shuttle platf ...

After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have ...

Digitized R&D workflows help cell therapy developers reduce manual data handling and accelerate biologics development.

In cell therapy applications, commonly employed cell purification platforms for large-scale isolation of immune or stem cells separate cells based on a single cell surface antigen. Enrichment based on ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg ...

Cellares operates its first commercial-scale Smart Factory in New Jersey, with additional facilities under construction in Europe and Japan.

Autolomous and Cellular Origins today announce end-to-end integration of their respective platforms, bringing full automation ...

Cell therapy, one of the most promising frontiers in modern medicine, holds the potential to cure once-incurable diseases such as cancer and genetic disorders. But for all its promise, manufacturing ...

Key Points Interested in Lineage Cell Therapeutics, Inc.? Here are five stocks we like better. Lineage Cell Therapeutics ...

Streamlining cell and gene therapy workflows with precise serological pipetting Cell and gene therapies are transforming the ...

Personalized cell therapies have emerged as powerful treatments for cancers and other diseases but producing them remains a complex engineering challenge. Unlike conventional drugs, each cell therapy ...